PathMap Experiment #000002 - Tags: #Epstein-Barr Virus Infections #Microglial Activation #cGAS-STING Signaling #Demyelinating Diseases #Latent EBV

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=2 Artificial General Intelligence LLC Claim Evaluated: Does chronic latent Epstein-Barr Virus (EBV) reactivation drive microglial activation and subsequent myelin destruction in Multiple Sclerosis via the activation of the cGAS-STING innate immune pathway? This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Assess cGAS-STING pathway activation in patient-derived microglial organoids following exposure to EBV-encoded viral proteins (e.g., EBNA1, LMP1). Evaluate the therapeutic efficacy of STING-specific inhibitors in an MS model with prior EBV/gammaherpesvirus sensitization. Quantify spatial cGAS-STING pathway protein expression in post-mortem MS brain lesions associated with viral reservoirs. 📊 Suggested Studies Longitudinal study of MS patients to correlate EBV reactivation markers with CSF cGAS-STING pathway inflammatory signatures. Cross-disease comparison of cGAS-STING activation markers in MS versus other neuroinflammatory disorders with known viral associations. Systematic evaluation of STING-targeting drugs on microglial metabolic reprogramming in autoimmune demyelination models. 📊 Swansons Literature Based Discovery Candidates Chronic EBV-reactivated microglial priming leads to ferroptosis-driven axonal damage via the cGAS-STING-dependent iron regulation axis. EBV-associated chronic microglial priming (41063265, 42025559) Neuronal ferroptosis and iron metabolism in MS (41702081) cGAS-STING-dependent upregulation of NCOA4 and iron overload. EBV-driven inflammation chronically primes microglia, leading to cytosolic mtDNA release, which activates cGAS-STING; STING signaling is known to facilitate ferroptotic signaling pathways, which in turn causes axonal loss. 📊 Contradictions Between Evidences There is conflicting evidence regarding the systemic role of IFN-I; while the STING-IFN-I pathway is generally considered a therapeutic target for suppression in inflammation, certain contexts (e.g., oxymatrine treatment) suggest that promoting IFN-β production via STING/TBK1/IRF3 can be protective in EAE, suggesting a dual-role or context-dependent regulation. 📊 Repurposed Solutions The use of STING inhibitors, originally developed for autoimmune conditions, can be repurposed for neurodegenerative conditions driven by sterile inflammation, such as Multiple Sclerosis and Epilepsy, to dampen the self-reinforcing microglia-Th17 activation loop. 🔖 Tags Attractor Table Extracted Keywords & Entities Epstein-Barr Virus Infections, _gates_from_epstein-barr_virus_infections, Microglial Activation, _gates_to_microglial_activation, _gates_from_microglial_activation, cGAS-STING Signaling, _gates_to_cgas-sting_signaling, _gates_from_cgas-sting_signaling, Demyelinating Diseases, _gates_to_demyelinating_diseases, Latent EBV, _gates_from_latent_ebv, cGAS-STING Activation, _gates_to_cgas-sting_activation, _gates_from_cgas-sting_activation, EBV latent infection, _gates_from_ebv_latent_infection, Exosomes, _gates_to_exosomes 🚀 Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.